PanGen Biotech Inc Working Capital to Net Assets Ratio
PanGen Biotech Inc working capital to net assets ratio. PanGen Biotech Inc (222110) has a Working Capital to Net Assets ratio of 68.6% as of September 2025. Working capital of ₩20.60 Billion (current assets of ₩23.34 Billion minus current liabilities of ₩2.74 Billion) is measured against net assets of ₩30.03 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check PanGen Biotech Inc (222110) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of PanGen Biotech Inc (2014–2024)
Working capital to net assets ratio of PanGen Biotech Inc from 2014 to 2024. This chart shows how PanGen Biotech Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 68.6%, reflecting working capital of ₩20.60 Billion against net assets of ₩30.03 Billion KRW. See PanGen Biotech Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
PanGen Biotech Inc Working Capital to Net Assets Ratio by Year (2014–2024)
PanGen Biotech Inc working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for PanGen Biotech Inc from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 222110 total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 71.7% | ₩17.87 Billion | ₩24.91 Billion | ₩20.77 Billion | ₩2.90 Billion | ▲ +38.9 pp |
| 2023 | 32.9% | ₩4.13 Billion | ₩12.57 Billion | ₩9.84 Billion | ₩5.71 Billion | ▼ -10.4 pp |
| 2022 | 43.2% | ₩7.45 Billion | ₩17.22 Billion | ₩8.58 Billion | ₩1.13 Billion | ▼ -10.2 pp |
| 2021 | 53.4% | ₩11.27 Billion | ₩21.10 Billion | ₩31.15 Billion | ₩19.89 Billion | ▲ +25.3 pp |
| 2020 | 28.2% | ₩4.00 Billion | ₩14.21 Billion | ₩24.09 Billion | ₩20.09 Billion | ▼ -8.2 pp |
| 2019 | 36.4% | ₩6.70 Billion | ₩18.43 Billion | ₩25.61 Billion | ₩18.91 Billion | ▼ -13.5 pp |
| 2018 | 49.9% | ₩13.44 Billion | ₩26.94 Billion | ₩30.87 Billion | ₩17.43 Billion | ▲ +3.2 pp |
| 2017 | 46.7% | ₩14.61 Billion | ₩31.31 Billion | ₩17.91 Billion | ₩3.29 Billion | ▼ -2.9 pp |
| 2016 | 49.6% | ₩17.51 Billion | ₩35.31 Billion | ₩18.70 Billion | ₩1.19 Billion | ▲ +113.5 pp |
| 2015 | -63.9% | ₩-4.19 Billion | ₩6.56 Billion | ₩1.77 Billion | ₩5.96 Billion | ▼ -72.8 pp |
| 2014 | 8.9% | ₩951.54 Million | ₩10.69 Billion | ₩4.03 Billion | ₩3.08 Billion | — |